WeChat Mini Program
Old Version Features

Advancing the PD-L1 CPS Test in Metastatic TNBC: Insights from Pathologists and Findings from a Nationwide Survey.

Nicola Fusco,Mariia Ivanova,Chiara Frascarelli,Carmen Criscitiello,Bruna Cerbelli,Maria Gemma Pignataro,Angelina Pernazza,Elham Sajjadi,Konstantinos Venetis,Giulia Cursano,Fabio Pagni,Camillo Di Bella,Marina Accardo, Michelina Amato,Paolo Amico,Caterina Bartoli,Giuseppe Bogina,Laura Bortesi,Renzo Boldorini, Sara Bruno,Daniela Cabibi,Pietro Caruana,Emanuele Dainese,Elisa De Camilli, Vladimiro Dell'Anna,Loren Duda,Carmela Emmanuele,Giuseppe Nicolo Fanelli,Bethania Fernandes,Gerardo Ferrara,Letizia Gnetti,Alessandra Gurrera,Giorgia Leone,Raffaella Lucci,Cristina Mancini, Grazia Marangi,Mauro G. Mastropasqua,Lorenzo Nibid,Sandra Orru, Maria Pastena, Monica Peresi,Letizia Perracchio,Angela Santoro,Vania Vezzosi,Claudia Zambelli,Valeria Zuccala,Antonio Rizzo,Leopoldo Costarelli,Francesca Pietribiasi,Alfredo Santinelli,Cristian Scatena,Giuseppe Curigliano,Elena Guerini-Rocco,Maurizio Martini,Paolo Graziano,Isabella Castellano,Giulia d'Amati

Critical Reviews in Oncology/Hematology（2023）

Cited 4|Views62
Key words
Breast cancer,TNBC,Biomarkers,PD-L1,CPS,Immunotherapy,SP263
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined